Serine protease inhibitor Kazal type 1 mutations and pancreatitis
- 31 December 2004
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 33 (4) , 789-806
- https://doi.org/10.1016/j.gtc.2004.07.005
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Clinical characterization of patients with idiopathic chronic pancreatitis and SPINK1 MutationsScandinavian Journal of Gastroenterology, 2004
- Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitisEuropean Journal of Human Genetics, 2003
- Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitutionThe Esophagus, 2002
- SPINK1 Is a Susceptibility Gene for Fibrocalculous Pancreatic Diabetes in Subjects from the Indian SubcontinentAmerican Journal of Human Genetics, 2002
- Hereditary pancreatitis: a model for inflammatory diseases of the pancreasBest Practice & Research Clinical Gastroenterology, 2002
- Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitisJournal of Medical Genetics, 2002
- The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the diseaseGut, 2002
- Molecular pathology and evolutionary and physiological implications of pancreatitis-associated cationic trypsinogen mutationsHuman Genetics, 2001
- Primary structure of human pancreatic secretory trypsin inhibitor (PSTI) geneBiochemical and Biophysical Research Communications, 1987
- Isolation of a Crystalline Trypsin Inhibitor-Anticoagulant Protein from Pancreas1aJournal of the American Chemical Society, 1948